Author name: TB Alliance

Dr. Tim McHugh Director University College London (UCL) Centre for Clinical Microbiology – REMox TB UCL Lead The microbiology laboratory

Dr Jane Rahedi Ong’ang’o Community Engagement Coordinator Kenya Medical Research Institute (KEMRI), Nairobi, Kenya In January 2010, the Phase III

Dr Stephen H. Gillespie MD DSc Sir James Black Professor of Medicine University of St Andrews University Chief Investigator For

Dr. Martin Springsklee Vice President – Head Global Medical Affairs Anti-Infectives at Bayer HealthCare We started our partnership with the

Prof. Charles Mgone Executive Director of the European and Developing Countries Clinical Trials Partnership (EDCTP) The enrolment of volunteers in

“The GFINDER report shows a large retraction of public funding, especially for product development partnerships (PDPs), which will have devastating

London – A fresh round of funding cuts from rich nations in the wake of the global financial crisis threaten

The meeting was convened to catalogue expert opinion on the conduct of Phase 2 and Phase 3 clinical trials in

Almari Uys of the TB Alliance was interviewed on Lotus FM Radio in South Africa. Conradie discussed the recent collaboration